Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your ...

Congressman Smith (R-NE) and Local Nebraska Officials Celebrate Inaugural Construction of NioCorp's Elk Creek Underground Mine Entrance in ...